Axastrol (anastrozolum) coated tablets 1 mg. №28

$226.20

Manufacturer: Cyprus

Purpose: Inhibits estrogen production for breast cancer treatment.

SKU: MED56712 Category:

Description

Axastrol (anastrozolum) coated tablets 1 mg. №28

Ingredients

Active ingredient: Anastrozole 1 mg.
Other ingredients: Lactose monohydrate, povidone, sodium starch glycolate, colloidal silicon dioxide, magnesium stearate, hypromellose, macrogol 300.

Dosage

Recommended dosage: 1 tablet daily, or as directed by a healthcare professional.
Swallow the tablet whole with a glass of water, with or without food.

Indications

Axastrol tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.

Contraindications

Do not use Axastrol tablets if you are allergic to anastrozole or any of the other ingredients in the product. Consult your doctor before use if you have liver problems.

Directions

Take Axastrol tablets exactly as prescribed by your healthcare provider. Do not exceed the recommended dosage. If you miss a dose, take it as soon as you remember.

Scientific Evidence

Anastrozole, the active ingredient in Axastrol tablets, is a selective aromatase inhibitor that has shown efficacy in the treatment of hormone receptor-positive breast cancer. Clinical studies have demonstrated its ability to reduce the risk of cancer recurrence and improve survival rates in postmenopausal women.

Additional Information

It is important to attend regular follow-up appointments with your healthcare provider while taking Axastrol tablets to monitor your response to the treatment and any potential side effects. Inform your doctor of any new symptoms or concerns.

Pharmacological Effects: Anastrozole works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens to estrogens. By reducing estrogen levels in the body, it helps slow or stop the growth of hormone receptor-positive breast cancer cells.

Clinical Trials: Clinical trials have shown that anastrozole is as effective as or more effective than tamoxifen in the treatment of early breast cancer, with a lower risk of certain side effects such as blood clots and endometrial cancer. Long-term studies have also demonstrated its benefits in reducing the risk of cancer recurrence.